Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1319141

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1319141

Global Autotransfusion System Market - 2023-2030

PUBLISHED:
PAGES: 195 Pages
DELIVERY TIME: 2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Market Overview

Global Autotransfusion System Market reached US$ 321.4 million in 2022 and is expected to reach US$ 482.6 million by 2030 growing with a CAGR of 5.3% during the forecast period 2023-2030.

Autotransfusion is a process wherein a person receives their own blood for a transfusion instead of banked allogenic (separate-donor) blood. The goal of autotransfusion remains the same, to maintain a sterile field, prevent clotting of the collected blood, filtration of the blood, and administration to the patient.

Market Dynamics

An Increase in the Incidence of Vascular Surgeries is Driving the Autotransfusion System Market

The major factor that is driving the autotransfusion market is the increase in the number of vascular surgeries. A number of people are suffering from vascular diseases, which are leading to autotransfusion treatment in order to avoid rejection.

For instance, according to the Journal of Vascular Surgery, 107 operations were performed annually. Among the defined cohort of vascular surgeons, 11% performed more than 200 procedures, and 21% performed fewer than 50. On average, 107 vascular procedures were performed annually by a vascular surgeon. Thus, increase in the number of vascular surgeries is increasing the market growth.

The rise in Technological Advancements is Demanding the Global Autotransfusion System Market Growth

The introduction of new technologies and developments in autotransfusion has been the drive for the autotransfusion system market. For instance, in 2022, NIH revealed a study stating that a medical device intended to collect and wash intra-operatively collected blood to obtain a concentrated blood product at the end of the process.

The device integrates an innovative filtration technology through hollow fibers, allowing RBCs concentration but also platelets within the concentrated blood product and contaminant elimination.Thus technological developments havebeen a drive for the autotransfusion system market.

A lack of Skilled Professionals to Perform the Procedure can Hamper the Market Growth

Less number of skilled professionals to perform the autotransfusion system better will decline the growth of the market. As there is an increase in the number of different kinds of surgeries there is a need foran ample number of professionals to treat the patients. Thus reduced count of skilled professionals can decline the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic epidemic has had a negative impact on the autotransfusion market. Many of the autotransfusion centers and diagnostic centers were closed, which has affected a large number of patients, and the transfusion rate has declined. The autotransfusion treatments have been postponed, which has created severe health issues This resulted in a significant increase in the number of patients lacking the treatment.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global autotransfusion system market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global autotransfusion system market growth over the forecast period.

Segment Analysis

The global autotransfusion system market is segmented based on product type, techniques, application, and end user.

The Cardiology Segment Holds the Dominant Position in the Market Over Forecast Period

Cardiology holds the most significant market share of around 41.7% during the forecast period. Autotransfusion of blood aspirated from the pericardium enables the operator to maintain hemodynamic stability (until surgery can be performed) and attempt to seal the cardiac perforation despite substantial and persistent fluid accumulation.

For instance, according to Lifespan Organization, there are about 500,000 open heart surgeries performed each year. It is most often used for complicated procedures, such as coronary artery bypass, or complex procedures to the aorta or the heart itself. An increase in surgeries required autotransfusion to be raised. Thus, the above factors are influencing the growth of the segment.

Geographical Analysis

Europe accounted for 27.9% of the Market Share Owing to the Prevalence of Surgeries and Increasing Technological Advancements

Due to the increased cardiac surgeries in this region ,there is an ample need for autotransfusion to be performed. The increase in the requirement for autotransfusion has increased the development of autotransfusion systems which has influenced the growth of the autotransfusion market in these regions.

For instance, according to CDS, 38 900 heart bypasses were conducted in Germany in 2020; this was more than double the number in any of the other EU Member States (16 400 were conducted in France). Hypertension is on the rise in Europe, especially in the rural and urban populations, which is increasing the incidence of cardiac surgeries.

Competitive Landscape

The major global players in the autotransfusion market include: BD, Fresenius Kabi, Zimmer, Armstrong Medical, Beijing ZKSK Technolgy, Haemonetics, LivaNova, Terumo BCT, Atrium Medical Corporation, Medtronic among others.

Why Purchase the Report?

  • To visualize the global autotransfusion system market segmentation based on product type, techniques, application, and end-user, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global autotransfusion system market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global autotransfusion system market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Product Code: MD6545

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by End User
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase in incidence of surgeries with maximum blood loss
      • 4.1.1.2. Increase in the unavailability of the donors
    • 4.1.2. Restraints
      • 4.1.2.1. High cost of an autotransfusion system
    • 4.1.3. Opportunity
      • 4.1.3.1. Technological advancements in product development
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Impact Analysis

8. By Product Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.1.2. Market Attractiveness Index, By Product Type
  • 8.2. Intraoperative Autotransfusion Systems*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Postoperative Autotransfusion Systems
  • 8.4. Dual-Mode Autotransfusion Systems
  • 8.5. Autotransfusion Accessories

9. By Techniques

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Techniques
    • 9.1.2. Market Attractiveness Index, By Techniques
  • 9.2. Predeposit autologous donation (PAD) *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Acute normovolaemic haemodilution (ANH)
  • 9.4. Perioperative cell salvage (PCS)

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Orthopedic*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Neurology
  • 10.4. Cardiology
  • 10.5. Others

11. By End User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.1.2. Market Attractiveness Index, By End User
  • 11.2. Hospitals *
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Specialty Clinics
  • 11.4. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.7.1. U.S.
      • 12.2.7.2. Canada
      • 12.2.7.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.7.1. Germany
      • 12.3.7.2. U.K.
      • 12.3.7.3. France
      • 12.3.7.4. Spain
      • 12.3.7.5. Italy
      • 12.3.7.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.7.1. Brazil
      • 12.4.7.2. Argentina
      • 12.4.7.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.7.1. China
      • 12.5.7.2. India
      • 12.5.7.3. Japan
      • 12.5.7.4. Australia
      • 12.5.7.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Armstrong Medical.
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. Beijing ZKSK Technology
  • 14.3. Medtronic
  • 14.4. Haemonetics
  • 14.5. LivaNova
  • 14.6. BD
  • 14.7. Zimmer
  • 14.8. Terumo BCT
  • 14.9. Atrium Medical Corporation
  • 14.10. Fresenius Kabi

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!